三鑫医疗：接受华创证券等投资者调研

Company Overview - Sanxin Medical (SZ 300453) announced that on October 30, 2025, it will accept investor inquiries, with key personnel including the Vice President and Secretary of the Board, Liu Ming, addressing investor questions [1] Financial Performance - For the first half of 2025, Sanxin Medical's revenue composition was as follows: 99.78% from the medical device industry and 0.22% from other businesses [1]